Cervical pathology. What tasks have a gynecologist?


  • Т. Ф Татарчук Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • Т. Н. Тутченко SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine», Ukraine




cervix, cervical background diseases, cervical precancerous, cervical cancer


Cervical pathological processes occupy a significant place in the structure of the reproductive system pathology and are found in 15-20% of women of reproductive age and in 5-9% of menopausal women. Cervical background diseases are cervical ectopia (pseudo erosion), cervical true erosion, ectropion, simple leukoplakia, cervical polyp, warts and flat condylomas. Early detection and treatment of cervical background diseases and precancerous cervical diseases can prevent cervical cancer, which ranks third in frequency among malignant tumors of the genital organs and the sixth in the structure of total cancer incidence. The article describes approaches to the classification, diagnostics, and treatment of pathological conditions of the cervix.

Author Biographies

Т. Ф Татарчук, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, professor, corresponding member. NAMS of Ukraine, Deputy Director for Research, Head of Endocrine Gynecology

Т. Н. Тутченко, SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine»

PhD, scientific researcher, Department of Endocrine Gynecology


  1. Ma CG, Chen MK, Yang SC, Bai S, Liao QM Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients. Int J STD AIDS. 2010 Jul; 21 (7): 528-9.
  2. Grimm C, Polterauer S, Natter C, Rahhal J, Hefler L, Tempfer CB, Heinze G, Stary G, Reinthaller A, Speiser P Treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 2012 Jul;120 (1): 152-9.
  3. de Sanjosй S, Muсoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, Gonzбlez LC, Tafur L, Gili M et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain .Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Int J Cancer. 1994 Feb 1; 56 (3): 358-63.
  4. Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia or Adenocarcinoma in situ. American Journal of Obstetrics and Gynecology, 2007.
  5. Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5 (7): 541-8.
  6. Bashyal R, Dali S Study on koilocytosis, X-chromatin and HSV-2 in cervical smears in Nepal. Nepal Med Coll J. 2004 Jun; 6 (1): 45-8.
  7. McAllum B, Sykes PH, Sadler L, Macnab H, Simcock BJ, Mekhail AK Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol. 2011 Nov; 205(5): 478.e1-7.
  8. Qian YS, Lv W, Sui LH, Wang J Study on the relationship between genesis and development of cervical cancer and the infection of human papillomavirus type 16/18, human herpesvirus II and cytomegalovirus. J Low Genit Tract Dis. 2003 Jul;7 (3): 187-93.
  9. Daxnerova Z, Berkova Z, Kaufman RH, Adam E Detection of human cytomegalovirus DNA in 986 women studied for human papillomavirus-associated cervical neoplasia. Tumori. 2011 Sep-Oct; 97 (5): 578-84.
  10. Misson DR, Abdalla DR, Borges AM, Shimba DS, Adad SJ, Michelin MA, Murta EF Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2β. Oncology Research Institute (IPON)/Discipline of Gynecology and Obstetrics, Federal University of the Triвngulo Mineiro (UFTM), Avenida Getelio Guarito, Uberaba (MG), Brazil, CEP 38025-440, Bairro Abadia.2011.
  11. Nath AK, Thappa DM Newer trends in the management of genital herpes. Indian J Dermatol Venereol Leprol 2009; 75: 566-74.
  12. Lebrun-Vignes B Valaciclovir. Ann Dermatol Venereol. 2002 May; 129 (5 Pt 1): 708-15.
  13. WHO guidelines. Use of cryotherapy for cervical intraepithelial neoplasia, 2011.
  14. National Guideline for the Management of Genital Herpes. British Association for Sexual Health and HIV.
  15. Zhao Y, Cao X, Zheng Y, Tang J, Cai W, Wang H, Gao Y, Wang Y Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. J Med Virol. 2012 Dec; 84 (12): 1920-7.
  16. Smith JS, Herrero R, Bosetti C, Muсoz N, Bosch FX, Eluf-Neto J, Castellsaguй X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. J Natl Cancer Inst. 2002 Nov 6; 94 (21): 1604-13.
  17. Tyring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol. 1998 Feb; 134 (2): 185-91.
  18. Rogovskaya SI Genital human papillomavirus infection: interferon role in the pathogenesis and treatment of STIs // Gynecology. – 2003. – № 5 (5). – P. 195-198.
  19. Zaporozhan VN, Dubinin, VG, Tatarchuk TF, Cossey NV, Islamova SA Timely diagnostic and treatment of endometrial hyperplastic processes. – Kyiv, Institute of Pediatrics, Obstetrics and Gynecology, Academy of Medical Sciences, 2012.
  20. Safronova MM Principles of diagnosis and treatment of genital herpes // Aqua Vitae. – 1997. – № 1.
  21. Kostava MN Cryosurgery and diathermocoagulation of benign cervical diseases: Clinical lectures, ed. VN Prilepskaya. – M., 2000. – P. 58-62.
  22. Udzhuhu VY, Petrunin DD, Gavrilenko AS Genferon in current treatment of urogenital infections. – M., 2007.
  23. Zalutsky IV Oncology. – Minsk, Higher School, 2007.
  24. WHO position on vaccines against human papillomavirus.Weekly Epidemiological Record Ref., 2005.
  25. Open, comparative, randomized, crossover trial for study drug VALAVIR ® bioequivalence to the reference drug on the basis of pharmacokinetics laboratory SI «State Expert Center of the Ministry of Health of Ukraine», 2011.
  26. Protocol «Benign and precancerous cervical processes». Annex to the Order of the Ministry of Health of Ukraine № 676 of 31.12.2004.
  27. Krasnopolsky VI, Logutova LS, Serova OF et al. Luteal phase defect: definition, diagnosis and differential treatment. Newsletter. – M., 2004.
  28. Centers for Disease Control and Prevention (CDC). Diseases characterized by genital, anal, or perianal ulcers. MMWR Recomm Rep 2010 Dec 17; 59 (RR-12): 18-39.



How to Cite

Татарчук, Т. Ф., & Тутченко, Т. Н. (2014). Cervical pathology. What tasks have a gynecologist?. REPRODUCTIVE ENDOCRINOLOGY, (9), 39–48. https://doi.org/10.18370/2309-4117.2013.9.39-48